Searcharxiv⌕ Search

arXiv subjects

Guo-Wei Wei

Publications and source records attributed to Guo-Wei Wei.

At least 109 records · Page 6Linked to original sources

Integrating Transformer and Autoencoder Techniques with Spectral Graph Algorithms for the Prediction of Scarcely Labeled Molecular Data

In molecular and biological sciences, experiments are expensive, time-consuming, and often subject to ethical constraints. Consequently, one often faces the challenging task of predicting desirable properties from small data sets or scarcely-labeled data sets. Although transfer learning can be advantageous, it requires the existence of a related large data set. This work introduces three graph-based models incorporating Merriman-Bence-Osher (MBO) techniques to tackle this challenge. Specifically, graph-based modifications of the MBO scheme are integrated with state-of-the-art techniques, including a home-made transformer and an autoencoder, in order to deal with scarcely-labeled data sets. In addition, a consensus technique is detailed. The proposed models are validated using five benchmark data sets. We also provide a thorough comparison to other competing methods, such as support vector machines, random forests, and gradient boosting decision trees, which are known for their good performance on small data sets. The performances of various methods are analyzed using residue-similarity (R-S) scores and R-S indices. Extensive computational experiments and theoretical analysis show that the new models perform very well even when as little as 1% of the data set is used as labeled data.

cs.LG↗

SVSBI: Sequence-based virtual screening of biomolecular interactions

Virtual screening (VS) is an essential technique for understanding biomolecular interactions, particularly, drug design and discovery. The best-performing VS models depend vitally on three-dimensional (3D) structures, which are not available in general but can be obtained from molecular docking. However, current docking accuracy is relatively low, rendering unreliable VS models. We introduce sequence-based virtual screening (SVS) as a new generation of VS models for modeling biomolecular interactions. The SVS model utilizes advanced natural language processing (NLP) algorithms and optimizes deep $K$-embedding strategies to encode biomolecular interactions without invoking 3D structure-based docking. We demonstrate the state-of-art performance of SVS for four regression datasets involving protein-ligand binding, protein-protein, protein-nucleic acid binding, and ligand inhibition of protein-protein interactions and five classification datasets for the protein-protein interactions in five biological species. SVS has the potential to dramatically change the current practice in drug discovery and protein engineering.

q-bio.BM↗

Emerging dominant SARS-CoV-2 variants

Accurate and reliable forecasting of emerging dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants enables policymakers and vaccine makers to get prepared for future waves of infections. The last three waves of SARS-CoV-2 infections caused by dominant variants Omicron (BA.1), BA.2, and BA.4/BA.5 were accurately foretold by our artificial intelligence (AI) models built with biophysics, genotyping of viral genomes, experimental data, algebraic topology, and deep learning. Based on newly available experimental data, we analyzed the impacts of all possible viral spike (S) protein receptor-binding domain (RBD) mutations on the SARS-CoV-2 infectivity. Our analysis sheds light on viral evolutionary mechanisms, i.e., natural selection through infectivity strengthening and antibody resistance. We forecast that BA.2.10.4, BA.2.75, BQ.1.1, and particularly, BA.2.75+R346T, have high potential to become new dominant variants to drive the next surge.

q-bio.PE↗

Topological AI forecasting of future dominating viral variants

The understanding of the mechanisms of SARS-CoV-2 evolution and transmission is one of the greatest challenges of our time. By integrating artificial intelligence (AI), viral genomes isolated from patients, tens of thousands of mutational data, biophysics, bioinformatics, and algebraic topology, the SARS-CoV-2 evolution was revealed to be governed by infectivity-based natural selection. Two key mutation sites, L452 and N501 on the viral spike protein receptor-binding domain (RBD), were predicted in summer 2020, long before they occur in prevailing variants Alpha, Beta, Gamma, Delta, Kappa, Theta, Lambda, Mu, and Omicron. Recent studies identified a new mechanism of natural selection: antibody resistance. AI-based forecasting of Omicron's infectivity, vaccine breakthrough, and antibody resistance was later nearly perfectly confirmed by experiments. The replacement of dominant BA.1 by BA.2 in later March was predicted in early February. On May 1, 2022, persistent Laplacian-based AI projected Omicron BA.4 and BA.5 to become the new dominating COVID-19 variants. This prediction became reality in late June. Topological AI models offer accurate prediction of mutational impacts on the efficacy of monoclonal antibodies (mAbs).

q-bio.QM↗

Persistent Path Laplacian

Path homology proposed by S.-T.Yau and his co-workers provides a new mathematical model for directed graphs and networks. Persistent path homology (PPH) extends the path homology with filtration to deal with asymmetry structures. However, PPH is constrained to purely topological persistence and cannot track the homotopic shape evolution of data during filtration. To overcome the limitation of PPH, persistent path Laplacian (PPL) is introduced to capture the shape evolution of data. PPL's harmonic spectra fully recover PPH's topological persistence and its non-harmonic spectra reveal the homotopic shape evolution of data during filtration.

math.AT↗

CCP: Correlated Clustering and Projection for Dimensionality Reduction

Most dimensionality reduction methods employ frequency domain representations obtained from matrix diagonalization and may not be efficient for large datasets with relatively high intrinsic dimensions. To address this challenge, Correlated Clustering and Projection (CCP) offers a novel data domain strategy that does not need to solve any matrix. CCP partitions high-dimensional features into correlated clusters and then projects correlated features in each cluster into a one-dimensional representation based on sample correlations. Residue-Similarity (R-S) scores and indexes, the shape of data in Riemannian manifolds, and algebraic topology-based persistent Laplacian are introduced for visualization and analysis. Proposed methods are validated with benchmark datasets associated with various machine learning algorithms.

stat.ML↗

Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants

Due to its high transmissibility, Omicron BA.1 ousted the Delta variant to become a dominating variant in late 2021 and was replaced by more transmissible Omicron BA.2 in March 2022. An important question is which new variants will dominate in the future. Topology-based deep learning models have had tremendous success in forecasting emerging variants in the past. However, topology is insensitive to homotopic shape variations in virus-human protein-protein binding, which are crucial to viral evolution and transmission. This challenge is tackled with persistent Laplacian, which is able to capture both the topology and shape of data. Persistent Laplacian-based deep learning models are developed to systematically evaluate variant infectivity. Our comparative analysis of Alpha, Beta, Gamma, Delta, Lambda, Mu, and Omicron BA.1, BA.1.1, BA.2, BA.2.11, BA.2.12.1, BA.3, BA.4, and BA.5 unveils that Omicron BA.2.11, BA.2.12.1, BA.3, BA.4, and BA.5 are more contagious than BA.2. In particular, BA.4 and BA.5 are about 36\% more infectious than BA.2 and are projected to become new dominating variants by natural selection. Moreover, the proposed models outperform the state-of-the-art methods on three major benchmark datasets for mutation-induced protein-protein binding free energy changes.

q-bio.BM↗

Mathematical artificial intelligence design of mutation-proof COVID-19 monoclonal antibodies

Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have compromised existing vaccines and posed a grand challenge to coronavirus disease 2019 (COVID-19) prevention, control, and global economic recovery. For COVID-19 patients, one of the most effective COVID-19 medications is monoclonal antibody (mAb) therapies. The United States Food and Drug Administration (U.S. FDA) has given the emergency use authorization (EUA) to a few mAbs, including those from Regeneron, Eli Elly, etc. However, they are also undermined by SARS-CoV-2 mutations. It is imperative to develop effective mutation-proof mAbs for treating COVID-19 patients infected by all emerging variants and/or the original SARS-CoV-2. We carry out a deep mutational scanning to present the blueprint of such mAbs using algebraic topology and artificial intelligence (AI). To reduce the risk of clinical trial-related failure, we select five mAbs either with FDA EUA or in clinical trials as our starting point. We demonstrate that topological AI-designed mAbs are effective to variants of concerns and variants of interest designated by the World Health Organization (WHO), as well as the original SARS-CoV-2. Our topological AI methodologies have been validated by tens of thousands of deep mutational data and their predictions have been confirmed by results from tens of experimental laboratories and population-level statistics of genome isolates from hundreds of thousands of patients.

q-bio.BM↗

Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly replaced the Delta variant as a dominating SARS-CoV-2 variant because of natural selection, which favors the variant with higher infectivity and stronger vaccine breakthrough ability. Omicron has three lineages or subvariants, BA.1 (B.1.1.529.1), BA.2 (B.1.1.529.2), and BA.3 (B.1.1.529.3). Among them, BA.1 is the currently prevailing subvariant. BA.2 shares 32 mutations with BA.1 but has 28 distinct ones. BA.3 shares most of its mutations with BA.1 and BA.2 except for one. BA.2 is found to be able to alarmingly reinfect patients originally infected by Omicron BA.1. An important question is whether BA.2 or BA.3 will become a new dominating "variant of concern". Currently, no experimental data has been reported about BA.2 and BA.3. We construct a novel algebraic topology-based deep learning model trained with tens of thousands of mutational and deep mutational data to systematically evaluate BA.2's and BA.3's infectivity, vaccine breakthrough capability, and antibody resistance. Our comparative analysis of all main variants namely, Alpha, Beta, Gamma, Delta, Lambda, Mu, BA.1, BA.2, and BA.3, unveils that BA.2 is about 1.5 and 4.2 times as contagious as BA.1 and Delta, respectively. It is also 30% and 17-fold more capable than BA.1 and Delta, respectively, to escape current vaccines. Therefore, we project that Omicron BA.2 is on its path to becoming the next dominating variant. We forecast that like Omicron BA.1, BA.2 will also seriously compromise most existing mAbs, except for sotrovimab developed by GlaxoSmithKline.

q-bio.PE↗

Machine learning analysis of cocaine addiction informed by DAT, SERT, and NET-based interactome networks

Cocaine addiction is a psychosocial disorder induced by the chronic use of cocaine and causes a large of number deaths around the world. Despite many decades' effort, no drugs have been approved by the Food and Drug Administration (FDA) for the treatment of cocaine dependence. Cocaine dependence is neurological and involves many interacting proteins in the interactome. Among them, dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) are three major targets. Each of these targets has a large protein-protein interaction (PPI) network which must be considered in the anti-cocaine addiction drug discovery. This work presents DAT, SERT, and NET interactome network-informed machine learning/deep learning (ML/DL) studies of cocaine addiction. We collect and analyze 61 protein targets out 460 proteins in the DAT, SERT, and NET PPI networks that have sufficient existing inhibitor datasets. Utilizing autoencoder and other ML algorithms, we build ML/DL models for these targets with 115,407 inhibitors to predict drug repurposing potentials and possible side effects. We further screen their absorption, distribution, metabolism, and excretion, and toxicity (ADMET) properties to search for nearly optimal leads for anti-cocaine addiction. Our approach sets up a systematic protocol for artificial intelligence (AI)-based anti-cocaine addiction lead discovery.

q-bio.MN↗

Geometric algebra generation of molecular surfaces

Geometric algebra is a powerful framework that unifies mathematics and physics. Since its revival in the middle of the 1960s by David Hestenes, it attracts great attention and has been exploited in many fields such as physics, computer science, and engineering. This work introduces a geometric algebra method for the molecular surface generation that utilizes the Clifford-Fourier transform which is a generalization of the classical Fourier transform. Notably, the classical Fourier transform and Clifford-Fourier transform differ in the derivative property in $R_k$ for k even. This distinction is due to the noncommutativity of geometric product of pseudoscalars with multivectors and has significant consequences in applications. We use the Clifford-Fourier transform in $R_3$ to benefit from the derivative property in solving partial differential equations (PDEs). The Clifford-Fourier transform is used to solve the mode decomposition process in PDE transform. Two different initial cases are proposed to make the initial shapes used in the present method. The proposed method is applied first to small molecules and proteins. To validate the method, the molecular surfaces generated are compared to surfaces of other definitions. Applications are considered to protein electrostatic analysis. This work opens the door for further applications of geometric algebra and Clifford-Fourier transform in biological sciences.

math.NA↗

Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance

The latest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant Omicron (B.1.1.529) has ushered panic responses around the world due to its contagious and vaccine escape mutations. The essential infectivity and antibody resistance of the SARS-CoV-2 variant are determined by its mutations on the spike (S) protein receptor-binding domain (RBD). However, a complete experimental evaluation of Omicron might take weeks or even months. Here, we present a comprehensive quantitative analysis of Omicron's infectivity, vaccine-breakthrough, and antibody resistance. An artificial intelligence (AI) model, which has been trained with tens of thousands of experimental data points and extensively validated by experimental data on SARS-CoV-2, reveals that Omicron may be over ten times more contagious than the original virus or about twice as infectious as the Delta variant. Based on 132 three-dimensional (3D) structures of antibody-RBD complexes, we unveil that Omicron may be twice more likely to escape current vaccines than the Delta variant. The Food and Drug Administration (FDA)-approved monoclonal antibodies (mAbs) from Eli Lilly may be seriously compromised. Omicron may also diminish the efficacy of mAbs from Celltrion and Rockefeller University. However, its impact on Regeneron mAb cocktail appears to be mild.

q-bio.QM↗

The evolution of the mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America

The importance of understanding SARS-CoV-2 evolution cannot be overemphasized. Recent studies confirm that natural selection is the dominating mechanism of SARS-CoV-2 evolution, which favors mutations that strengthen viral infectivity. We demonstrate that vaccine-breakthrough or antibody-resistant mutations provide a new mechanism of viral evolution. Specifically, vaccine-resistant mutation Y449S in the spike (S) protein receptor-bonding domain (RBD), which occurred in co-mutation [Y449S, N501Y], has reduced infectivity compared to the original SARS-CoV-2 but can disrupt existing antibodies that neutralize the virus. By tracing the evolutionary trajectories of vaccine-resistant mutations in over 1.9 million SARS-CoV-2 genomes, we reveal that the occurrence and frequency of vaccine-resistant mutations correlate strongly with the vaccination rates in Europe and America. We anticipate that as a complementary transmission pathway, vaccine-resistant mutations will become a dominating mechanism of SARS-CoV-2 evolution when most of the world's population is vaccinated. Our study sheds light on SARS-CoV-2 evolution and transmission and enables the design of the next-generation mutation-proof vaccines and antibody drugs.

q-bio.PE↗

MLIMC: Machine learning-based implicit-solvent Monte Carlo

Monte Carlo (MC) methods are important computational tools for molecular structure optimizations and predictions. When solvent effects are explicitly considered, MC methods become very expensive due to the large degree of freedom associated with the water molecules and mobile ions. Alternatively implicit-solvent MC can largely reduce the computational cost by applying a mean field approximation to solvent effects and meanwhile maintains the atomic detail of the target molecule. The two most popular implicit-solvent models are the Poisson-Boltzmann (PB) model and the Generalized Born (GB) model in a way such that the GB model is an approximation to the PB model but is much faster in simulation time. In this work, we develop a machine learning-based implicit-solvent Monte Carlo (MLIMC) method by combining the advantages of both implicit solvent models in accuracy and efficiency. Specifically, the MLIMC method uses a fast and accurate PB-based machine learning (PBML) scheme to compute the electrostatic solvation free energy at each step. We validate our MLIMC method by using a benzene-water system and a protein-water system. We show that the proposed MLIMC method has great advantages in speed and accuracy for molecular structure optimization and prediction.

q-bio.BM↗

Proteome-informed machine learning studies of cocaine addiction

Cocaine addiction accounts for a large portion of substance use disorders and threatens millions of lives worldwide. There is an urgent need to come up with efficient anti-cocaine addiction drugs. Unfortunately, no medications have been approved by the Food and Drug Administration (FDA), despite the extensive effort in the past few decades. The main challenge is the intricate molecular mechanisms of cocaine addiction, involving synergistic interactions among proteins upstream and downstream of dopamine transporter (DAT) functions impacted by cocaine. However, traditional in vivo or in vitro experiments can not address the roles of so many proteins, highlighting the need for innovative strategies in the field. We propose a proteome-informed machine learning/deep learning (ML/DL) platform to discover nearly optimal anti-cocaine addiction lead compounds. We construct and analyze proteomic protein-protein interaction (PPI) networks for cocaine dependence to identify 141 involved drug targets and represent over 60,000 associated drug candidates or experimental drugs in the latent space using an autoencoder (EA) model trained from over 104 million molecules. We build 32 ML models for cross-target analysis of these drug candidates for side effects and repurposing potential. We further screen the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these candidates. Our platform reveals that essentially all of the existing drug candidates, including dozens of experimental drugs, fail to pass our cross-target and ADMET screenings. Nonetheless, we have identified two nearly optimal leads for further optimization.

q-bio.MN↗

Review of the mechanisms of SARS-CoV-2 evolution and transmission

The mechanism of SARS-CoV-2 evolution and transmission is elusive and its understanding, a prerequisite to forecast emerging variants, is of paramount importance. SARS-CoV-2 evolution is driven by the mechanisms at molecular and organism scales and regulated by the transmission pathways at the population scale. In this review, we show that infectivity-based natural selection was discovered as the mechanism for SARS-CoV-2 evolution and transmission in July 2020. In April 2021, we proved beyond all doubt that such a natural selection via infectivity-based transmission pathway remained the sole mechanism for SARS-CoV-2 evolution. However, we reveal that antibody-disruptive co-mutations [Y449S, N501Y] debuted as a new vaccine-resistant transmission pathway of viral evolution in highly vaccinated populations a few months ago. Over one year ago, we foresaw that mutations spike protein RBD residues, 452 and 501, would "have high chances to mutate into significantly more infectious COVID-19 strains". Mutations on these residues underpin prevailing SARS-CoV-2 variants Alpha, Beta, Gamma, Delta, Epsilon, Theta, Kappa, Lambda, and Mu at present and are expected to be vital to emerging variants. We anticipate that viral evolution will combine RBD co-mutations at these two sites, creating future variants that are tens of times more infectious than the original SARS-CoV-2. Additionally, two complementary transmission pathways of viral evolution: infectivity and vaccine-resistant, will prolong our battle with COVID-19 for years. We predict that RBD co-mutation [A411S, L452R, T478K], [L452R, T478K, N501Y], [L452R, T478K, E484K, N501Y], [K417N, L452R, T478K], and [P384L, K417N, E484K, N501Y] will have high chances to grow into dominating variants due to their high infectivity and/or strong ability to break through current vaccines, calling for the development of new vaccines and antibody therapies.

q-bio.PE↗

Emerging vaccine-breakthrough SARS-CoV-2 variants

The recent global surge in COVID-19 infections has been fueled by new SARS-CoV-2 variants, namely Alpha, Beta, Gamma, Delta, etc. The molecular mechanism underlying such surge is elusive due to 4,653 non-degenerate mutations on the spike protein, which is the target of most COVID-19 vaccines. The understanding of the molecular mechanism of transmission and evolution is a prerequisite to foresee the trend of emerging vaccine-breakthrough variants and the design of mutation-proof vaccines and monoclonal antibodies. We integrate the genotyping of 1,489,884 SARS-CoV-2 genomes isolates, 130 human antibodies, tens of thousands of mutational data points, topological data analysis, and deep learning to reveal SARS-CoV-2 evolution mechanism and forecast emerging vaccine-escape variants. We show that infectivity-strengthening and antibody-disruptive co-mutations on the S protein RBD can quantitatively explain the infectivity and virulence of all prevailing variants. We demonstrate that Lambda is as infectious as Delta but is more vaccine-resistant. We analyze emerging vaccine-breakthrough co-mutations in 20 countries, including the United Kingdom, the United States, Denmark, Brazil, and Germany, etc. We envision that natural selection through infectivity will continue to be the main mechanism for viral evolution among unvaccinated populations, while antibody disruptive co-mutations will fuel the future growth of vaccine-breakthrough variants among fully vaccinated populations. Finally, we have identified the co-mutations that have the great likelihood of becoming dominant: [A411S, L452R, T478K], [L452R, T478K, N501Y], [V401L, L452R, T478K], [K417N, L452R, T478K], [L452R, T478K, E484K, N501Y], and [P384L, K417N, E484K, N501Y]. We predict they, particularly the last four, will break through existing vaccines. We foresee an urgent need to develop new vaccines that target these co-mutations.

q-bio.BM↗

Multiscale Laplacian Learning

Machine learning methods have greatly changed science, engineering, finance, business, and other fields. Despite the tremendous accomplishments of machine learning and deep learning methods, many challenges still remain. In particular, the performance of machine learning methods is often severely affected in case of diverse data, usually associated with smaller data sets or data related to areas of study where the size of the data sets is constrained by the complexity and/or high cost of experiments. Moreover, data with limited labeled samples is a challenge to most learning approaches. In this paper, the aforementioned challenges are addressed by integrating graph-based frameworks, multiscale structure, modified and adapted optimization procedures and semi-supervised techniques. This results in two innovative multiscale Laplacian learning (MLL) approaches for machine learning tasks, such as data classification, and for tackling diverse data, data with limited samples and smaller data sets. The first approach, called multikernel manifold learning (MML), integrates manifold learning with multikernel information and solves a regularization problem consisting of a loss function and a warped kernel regularizer using multiscale graph Laplacians. The second approach, called the multiscale MBO (MMBO) method, introduces multiscale Laplacians to a modification of the famous classical Merriman-Bence-Osher (MBO) scheme, and makes use of fast solvers for finding the approximations to the extremal eigenvectors of the graph Laplacian. We demonstrate the performance of our methods experimentally on a variety of data sets, such as biological, text and image data, and compare them favorably to existing approaches.

cs.LG↗